FKnol.com

Financial Knowledge & Information Portal

Best Performing Biotech Stocks of 2020

Updated Feb 14, 2020
Biotech, or biotechnology, is defined as the exploitation and use of biological processes for industrial, commercial and other requirements, especially the genetic manipulation of microorganisms for the generation, production and development of medicinal elements like antibiotics and hormones which can be used for therapeutic use. It is the technology that uses biological systems, living organisms or their parts to build and develop different products. The specialized sub-sector falls within the larger health care sector and involves activities like drug development, research, manufacturing and marketing in the field of biotech.
Among the big basket of Biotech stocks, which ones generated the top returns this year? Which of those figured among the winners in the long list of Biotech stocks?
This article provides a list of Biotech stocks which have generated the highest returns in the year 2020 so far. till date of writing. The list is prepared based on the percentage returns generated by the individual Biotech stocks between the end of the previous year and Feb 14, 2020, and the top 10 return generating Biotech stocks are listed below.
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Top Performing Biotech StocksAll Biotech StocksAll Biotech ETFsTop Dividend-paying Biotech StocksTop Biotech Stocks for Q1 2020

Top Biotech Stocks With Highest Returns

The following list presents stocks of the companies which belong to the broader Biotech sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized:
 1) Genprex, Inc. (GNPX) 2) Cleveland BioLabs, Inc. (CBLI) 3) Intrexon Corporation (XON) 4) Adaptimmune Therapeutics plc (ADAP) 5) Trillium Therapeutics Inc. (TRIL)
 6) Vaxart, Inc. (VXRT) 7) Aduro Biotech, Inc. (ADRO) 8) BioXcel Therapeutics, Inc. (BTAI) 9) Sunesis Pharmaceuticals, Inc. (SNSS) 10) CytRx Corporation (CYTR)
There's more... See price performance, YTD-gains, market-cap and other details of all the 449 Biotech stocks with sorting features in a tabular format. Alternatively, one can also explore the List of Top Biotech ETFs.

Top Performing Biotech StocksAll Biotech StocksAll Biotech ETFsTop Dividend-paying Biotech StocksTop Biotech Stocks for Q1 2020

Performance of Top Biotech Stocks

Here's a look at the basic details and how the above mentioned stocks fared during the period:

Genprex

Genprex, Inc., a clinical-stage gene therapy biotechnology company, develops immunogene therapy products for treating cancer. Its lead drug candidate is Oncoprex, which is in Phase II clinical trials for the tr ... see Detailed Company Profile and Dividend History.
The Austin, TX-based Genprex, Inc. (GNPX) belongs to the Health Care sector and is categorized as a Healthcare company. The stock of Genprex ended the previous year at a price of $0.32 per share. As of Feb 14, 2020, the stock price has reached $4.28 apiece, which indicates a change of 1237.5 percent making the company rank among the top performing stocks of the Biotech for the year 2020 till date. At the end of the last year, company's market capitalization stood at $6.16 million. It has now changed to $180.44 million as of writing.

Cleveland BioLabs

Cleveland BioLabs, Inc. (CBLI), incorporated on June 5, 2003, is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. ... see Detailed Company Profile and Dividend History.
Rank number two in the coveted list is held by Cleveland BioLabs, Inc. (CBLI) for being among the top performing stocks of 2020. Headquartered in New York, NY, the Health Care sector company is categorized under the industrial sub-sector of Biotech-Commercial Physical Biological Research. Since the start of the year 2020, stock of Cleveland BioLabs has so far gained 265 percentage, based on the previous year's closing price of $0.6 per share and year-to-date price of $2.19 per share. During the same period, the market capitalization of the company changed from $6.8 million to $24.74 million. The stock of Cleveland BioLabs continues to be a major constituent of many leading stock indexes which include Wilshire 5000 index, and several other broader level multi-cap market indicators.

Intrexon

Intrexon Corporation (Intrexon), incorporated on May 21, 2014, forms collaborations to create biologically-based products and processes using synthetic biology. The Companys domestic operations are in California, Florida, Maryland, and Virginia, ... see Detailed Company Profile and Dividend History.
During the given months of the year 2020, Intrexon Corporation (XON) was successful in generating YTD returns of 247.99 percentage which helped it gain the number three spot in the list of the top performing stocks which generated maximum returns during year 2020 till date. As of December of the previous year, the stock of the Germantown, MD, United States-based Intrexon closed at a price of $5.48 per share, while it traded at a price of $19.07 per share as of Feb 14, 2020. The company's market cap changed from $891.5 million to $3.24 billion during the same period YTD. It ranks as a key constituent of major indexes that include Wilshire 5000 index, Russell 2000 index, and several other broader level multi-cap market indicators. The company is classified under the Health Care industry sector and further specialized as a Biotech-Commercial Physical Biological Research sector business.

Adaptimmune Therapeutics

Adaptimmune Therapeutics plc, incorporated on December 03, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) ... see Detailed Company Profile and Dividend History.
Adaptimmune Therapeutics plc (ADAP) has moved by 235 percentage over the given period of 2020-YTD, helping it gain a place at number four among the top performing stocks. The Health Care sector company managed to achieve the feat as its stock price changed from $1.2 apiece to the price of $4.02 per share between the end of December of the previous year and Feb 14, 2020. The smart run of the United Kingdom-based Biotech Biological Products sector company lead to a handsome gain in its marketcap which changed from $126.2 million to $495.65 million over the same duration.

Trillium Therapeutics

Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced hematologic malignancies, and solid ... see Detailed Company Profile and Dividend History.
Based on the market-cap change from $28.62 million to $257.93 million during the given months of the year 2020 and the share price change from $1.03 per share to a price of $3.44 per share as of Feb 14, 2020, Trillium Therapeutics Inc. (TRIL) was successful in generating YTD returns of 233.98 percentage. Standing at the number five rank in the top performing list of Biotech stocks, the Canada-based Trillium Therapeutics is categorized as the Major Pharmaceuticals sub-sector business which falls under the larger Health Care sector.

Vaxart

Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. It is also developing therapeutic immune-oncology vaccines ... see Detailed Company Profile and Dividend History.
At number six in the list of top stocks stands Vaxart, Inc. (VXRT), which saw a change in its stock price from the level of $0.35 apiece during previous year December end to the price of $1.1 per share as of Feb 14, 2020. It translates to a change of 214.29 percentage. The USA-headquartered Health Care sector company also saw its market value change from $17.09 million to $56.57 million. The Healthcare specialist also managed to outperform some of the major stock market indexes of which it is a part of. They include the Wilshire 5000 index, and a handful of other multi-capitalization indexes.

Aduro Biotech

Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ... see Detailed Company Profile and Dividend History.
Aduro Biotech (ADRO) generated percentage returns of 186.44 percent during the 2020 year-to-date. Its returns are based on the share price which moved from $1.18 per share from the previous year-end to the price of $3.38 per share as of Feb 14, 2020. The company's value, as indicated by the market-cap figure, changed from $95.01 million to $296.04 million during the same period.
The company is categorized as a Health Care speciality business with further classification in the Major Pharmaceuticals sub-category. Based in California, CA, the YTD performance of the Biotech sector also fared better than that of the returns generated by some of the closley tracked stock market indexes. The company is a part of Wilshire 5000 index, Russell 2000 index, and a few other wider multi-cap stock market indexes.

BioXcel Therapeutics

BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. Th ... see Detailed Company Profile and Dividend History.
The number eight spot in the list of top performing stocks of the Biotech sector is taken by BioXcel Therapeutics, Inc. (BTAI). The company's stock price changed from $14.61 per share at the end of December of the previous year to the price of $36.97 per share as of writing. Overall, the stock managed to realized price change of 153.05 percent during the given time period. The corresponding change in the market capitalization value of the Branford, CT-based Health Care sector company was from $263.49 million to $666.75 million. Being ranked in the top 10 best performing stocks of the Biotech sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes. They include the Russell 2000 index, and a handful of other multi-capitalization indexes.

Sunesis Pharma

Sunesis Pharmaceuticals, Inc., incorporated on February 10, 1998, is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of ... see Detailed Company Profile and Dividend History.
The California, CA-headquartered company Sunesis Pharmaceuticals, Inc. (SNSS) is ranked number nine among the best performing stocks of Biotech of 2020. The Health Care sector business falls under the Major Pharmaceuticals industrial sub-sector. Since the start of the year 2020, the stock price of Sunesis Pharma has changed by 147.03 percent, which is calculated based on the previous year's closing price of $0.34 per share and year-to-date closing price of $0.84 per share as of writing. The market value of the company as indicated by its market-cap changed from $37.59 million to $102.99 million during the same period. Along with Biotech, the company is also in the business of Health Care, Major Pharmaceuticals, Biotechnology, Healthcare, among other usual products and services. Sunesis Pharma continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and a few other larger indexes which are part of the stock market.

CytRx

CytRx Corporation, incorporated on February 28, 1985, is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version ... see Detailed Company Profile and Dividend History.
The California, CA-based Health Care sector company CytRx Corporation (CYTR) holds the ten spot among the best performing stocks of the Biotech sector. Classified as the Biotech Biological Products business, the stock price of CytRx ended the previous year at a price of $0.29 per share while it reached the level of $0.64 apiece as of Feb 14, 2020 translating to a percentage change in stock price of 118.97%. As of writing, the company's market-cap value stands at $21.36 million. Few leading stock market index includes CytRx in their constituent list. They include Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Popular Investment Lists:

 ◐ Best Performing Low Beta Stocks of 2020-YTD

 ◐ Best Performing Dividend Aristocrats Stocks of 2020-YTD

 ◐ Best Performing High Beta Stocks of 2020-YTD

 ◐ Best Performing Basic Materials Stocks of 2020-YTD

 ◐ Best Performing Basic Industries Stocks of 2020-YTD

 ◐ Best Performing Healthcare Stocks of 2020-YTD

 ◐ Best Performing Pharma Stocks of 2020-YTD

 ◐ Best Performing Private Equity Stocks of 2020-YTD

 ◐ Best Performing ESG Stocks of 2020-YTD

 ◐ Best Performing Semiconductors Stocks of 2020-YTD

 ◐ Best Performing Brazil Stocks of 2020-YTD

 ◐ Best Performing Robotics Stocks of 2020-YTD

 ◐ Best Performing Tobacco Stocks of 2020-YTD

 ◐ Best Performing Fast Food Stocks of 2020-YTD

 ◐ Best Performing Coffee Stocks of 2020-YTD

 ◐ Best Performing Newspaper Stocks of 2020-YTD

 ◐ Best Performing Transportation Stocks of 2020-YTD

 ◐ Best Performing Precious Metals Stocks of 2020-YTD

 ◐ Best Performing Mexican Stocks of 2020-YTD

 ◐ Best Performing Indian Stocks of 2020-YTD

 ◐ Best Performing Renewable Energy Stocks of 2020-YTD

 ◐ Best Performing Russia Stocks of 2020-YTD

 ◐ Best Performing Water Stocks of 2020-YTD

 ◐ Best Performing Agriculture Stocks of 2020-YTD

 ◐ Best Performing Airlines Stocks of 2020-YTD

 ◐ Best Performing Blockchain Stocks of 2020-YTD

 ◐ Best Performing Natural Resources Stocks of 2020-YTD

 ◐ Best Performing Internet Stocks of 2020-YTD

 ◐ Best Performing Bank Stocks of 2020-YTD

 ◐ Best Performing Meat Stocks of 2020-YTD

 ◐ Best Performing Gaming Stocks of 2020-YTD

 ◐ Best Performing Biofuels Stocks of 2020-YTD

 ◐ Best Performing Software Stocks of 2020-YTD

 ◐ Best Performing China Stocks of 2020-YTD

 ◐ Best Performing Telecom Stocks of 2020-YTD

 ◐ Best Performing Biotech Stocks of 2020-YTD

 ◐ Best Performing Aluminum Stocks of 2020-YTD

 ◐ Best Performing Low Volatility Stocks of 2020-YTD

 ◐ Best Performing REIT Stocks of 2020-YTD

 ◐ Best Performing 5G Stocks of 2020-YTD

 ◐ Best Performing Dogs of the Dow Stocks of 2020-YTD

 ◐ Best Performing Palladium Stocks of 2020-YTD

 ◐ Best Performing Platinum Stocks of 2020-YTD

 ◐ Best Performing Silver Stocks of 2020-YTD

 ◐ Best Performing Gold Stocks of 2020-YTD

 ◐ Best Performing Iron Stocks of 2020-YTD

 ◐ Best Performing Steel Stocks of 2020-YTD

 ◐ Best Performing Dow Jones Stocks of 2020-YTD

 ◐ Best Performing NASDAQ Stocks of 2020-YTD

 ◐ Best Performing S&P 500 Stocks of 2020-YTD

 ◐ Top Companies By Market Value

 ◐ Market Cap of S&P 500 Companies of 2020-YTD

 ◐ See All Common Lists

 Search This Site